Clinical Trials Logo

Febrile Illness clinical trials

View clinical trials related to Febrile Illness.

Filter by:

NCT ID: NCT06422338 Not yet recruiting - Child, Only Clinical Trials

A Rapid Triage Test to Improve Risk-stratification of Febrile Children (EChiLiBRiST, Clinical Trial 1, Outpatients)

Start date: December 1, 2024
Phase: N/A
Study type: Interventional

The overall aim of the study is to provide evidence that introducing soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) evaluation at triaging (first clinical assessment), in combination with IMCI-based guidelines (SoC), is a viable strategy to enhance rapid and accurate identification of febrile children at increased risk of life-threatening infections compared to IMCI-based strategies alone (SoC), and to demonstrate whether this results in enhanced decisions of admission/referral vs discharge, and enhanced overall health outcome of children with acute fever in sub-Saharan Africa.

NCT ID: NCT06122259 Recruiting - Febrile Illness Clinical Trials

Febrile Illness in Guinea

MuSIFe
Start date: March 27, 2023
Phase:
Study type: Observational [Patient Registry]

To date, the underlying causes of community-acquired fever, particularly non-malarial fever, are insufficiently documented in Guinea. Moreover, diagnostic capacity is limited, leading to inadequate prescription of antibiotics and antimalarials, as well as substantial delay in outbreak recognition. Thus, the investigators undertook a prospective observational multi-centric cohort study of febrile patients presenting at the emergency and outpatient department of selected health centers, districts and regional hospitals in four ecologically distinct sentinel health districts in Guinea.

NCT ID: NCT06056011 Enrolling by invitation - Febrile Illness Clinical Trials

Timmy3 Module Clinical Accuracy ISO 80601-2-56:2017 + A1 2018

Start date: February 19, 2024
Phase: N/A
Study type: Interventional

The purpose of this document is to validate the clinical accuracy of the TIMMY3 thermometry module, integrated into host device CVSM, according to ISO 80601-2-56:2017 + A1 2018.

NCT ID: NCT05850013 Recruiting - Clinical trials for Cardiovascular Diseases

The Measurement of Vital Signs in Children by Lifelight® Software in Comparison to the Standard of Care

VISION-Jr
Start date: May 1, 2023
Phase:
Study type: Observational

A prospective basic science study for collection of training and testing data for development of Lifelight® Junior

NCT ID: NCT05721131 Completed - Healthy Clinical Trials

NC Thermometer (Gen 3) ISO 80601-2-56 Validation

Start date: January 10, 2023
Phase:
Study type: Observational

The purpose of this clinical validation is to evaluate the the clinical bias, the limits of agreement, and the clinical repeatability of measuring oral temperature using a new thermometer, NC° Thermometer (Gen 3), compared to a reference clinical thermometer.

NCT ID: NCT05640310 Withdrawn - Healthy Clinical Trials

Prospective Study to Validate the Clinical Accuracy of Norbert Device to Measure Body Temperature

Start date: March 2023
Phase:
Study type: Observational

The study will evaluate the clinical bias and clinical repeatability of measuring body temperature using the Norbert Device (ND).

NCT ID: NCT05441800 Recruiting - Febrile Illness Clinical Trials

Epidemiology and Clinical Characteristics of Emerging and Re-emerging Infectious Diseases With Epidemic Potential in Mali

ECERID
Start date: June 18, 2020
Phase:
Study type: Observational [Patient Registry]

This is a prospective observational study to include participants with a spectrum of emerging or unknown pathogens with the objective to determine etiology and clinical characteristics of those diseases.

NCT ID: NCT05045547 Recruiting - Febrile Illness Clinical Trials

Village Malaria Worker Expansion

CAM-VMW
Start date: February 17, 2022
Phase:
Study type: Observational

This project will conduct pragmatic operational research in rural communities served by approximately 12 health centres and 120 village malaria workers in Battambang/Pailin, western Cambodia. This study is funded by Global Fund/Regional Artemisinin Initiative (RAI3E). The grant reference number is QSE-M-UNOPS-MORU-20864-007-42

NCT ID: NCT04925401 Completed - Stress Clinical Trials

Evaluation of Knowledge About Fever After Consultation in the Pediatric Emergency Department

FEARVER
Start date: November 2, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effect of an information brochure on parent / legal guardians' knowledge of what to do about their child's febrile episode after a pediatric emergency department visit. Single-center randomized controlled trial.

NCT ID: NCT04760678 Active, not recruiting - Febrile Illness Clinical Trials

Febrile Illness in Kinshasa and Kimpese

FIKI²
Start date: March 1, 2021
Phase:
Study type: Observational

This is a bi-centric prospective observational cohort study of adults and children presenting to the emergency room or outpatient department with community febrile illness (with or without signs of focalization) in 2 clinical sites (hospitals) in the DRC. The study will describe the epidemiology, clinical aspects, severity, management and outcome of febrile illnesses using data collected during routine diagnostic and therapeutic procedures. Each patient will be followed for 21 days. The follow-up will include - Daily visits for hospitalized patients, - Telephone calls (or study center visit or home visit) on days 7, 14 and 21 for outpatients and discharged patients. The study has been amended (EC UZA approval in June 2021) to perform a set of laboratory analyses in the partners institutions and at the ITM. We aim as a new primary objective at describing the profile of different biomarkers (C-reactive protein and white blood cell count with differentiation) in participants enrolled with febrile illness, and as secondary objectives to correlate them with outcome (assessed at day 21) and with several etiological diagnoses, especially malaria (as assessed by rapid diagnostic test and blood smear). The purpose is to investigate the potential diagnostic and prognostic value of these biomarkers which are increasingly available at the point-of-care.